The 4th edition of the Narture International Summit – an international event organised by IBSA that combines science, art, nature and Artificial Intelligence in order to redefine the boundaries of reproductive medicine – was held in Lugano (CH) from 20 to 22 September. With the participation of 250 experts, the Summit explored the latest technological innovations, promoting a multidisciplinary debate and showing how artificial intelligence can accelerate progress in the ART sector and improve patients’ quality of life. 🔹 Find out all the details in our latest news: https://lnkd.in/e7nzmzGe #IBSA #CaringInnovation #Narture #ReproductiveMedicine Laura Rienzi, Shari Mackens, Dominique de Ziegler, Peter Humaidan, Nikolaos Polyzos, Richard Anderson, Catherine Rackowsky, Paola Fasola, Marialuisa Fino, Paola Quagliucci, Linda Lamberti, IBSA Austria, IBSA France, IBSA Germany, IBSA Iberia, IBSA Italy, IBSA Nordic, IBSA Poland, IBSA Slovakia, IBSA Switzerland | SBO, IBSA UK, IBSA USA
Info
IBSA Institut Biochimique SA is a privately owned pharmaceutical company founded in Lugano in 1945. It started to develop its specific identity in 1985, when the current management took over, redefining its strategy and focusing on developing technologies that improve the quality of existing therapeutic solutions. Today, it is present on 5 continents and over 90 countries. The Group now counts on 20 subsidiaries in Europe, China and USA, and boasts a product portfolio covering 10 therapeutic areas. The company employs over 2,300 people, distributed among its headquarters, subsidiaries and manufacturing sites. IBSA is one of the four largest operators worldwide in the area of Reproductive Medicine and one of the world's leaders in hyaluronic acid-based products. Therapeutic areas: 🔹 Reproductive Medicine 🔹 Endocrinology 🔹 Pain and Inflammation 🔹 Osteoarticular 🔹 Aesthetic Medicine 🔹 Dermatology 🔹 Uro-gynaecology 🔹 Cardiometabolic 🔹 Respiratory 🔹 Consumer Health
- Website
-
http://www.ibsagroup.com/
Externer Link zu IBSA Group
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Lugano, Svizzera
- Art
- Privatunternehmen
- Spezialgebiete
- Pharmaceutical , Pharma Industry, R&D, cardiovascular, dermatology, dermoaesthetic, endocrinology, fertility, human reproduction, respiratory, rheumatology, pain, inflammation, urology und drugs
Orte
-
Primär
Via del Piano 29
Lugano, Svizzera CH-6915, CH
Beschäftigte von IBSA Group
Updates
-
CPHI has reached its 35th edition and once again IBSA confirms its participation. From 8 to 10 October, we will be present at one of the most relevant events for the pharmaceutical sector, to explore new business opportunities, present our technological innovations and promote collaboration between experts and professionals from all over the world. 🔹 See you at our stand, 14A30! #IBSA #Caringinnovation #cphimilan2024 #innovation #pharma Andrea Taborelli, Shawn Valenti, Beatrice Pisano
-
In a world first, a half-face transplant – eye included – has been performed at NYU Langone Health, on a 47-year-old man. The successful procedure took 21 hours and kept the eye tissue alive, even if the optic nerve couldn’t be regenerated. 🔹 Find out more in the latest IBSA Foundation for scientific research blog article: https://lnkd.in/dnRzgxHs #IBSA #CaringInnovation #ScienceBeyondFrontiers #IBSAFoundation #science #transplant #surgery
-
Are you a young researcher? Would you like to win one of the 6 fellowships of IBSA Foundation for scientific research? Here are the eligibility criteria: 🔬 Age: under 40 🎓 Degree: degree in medicine, biology, pharmacy, biotechnology or bioengineering 💼 Professional profile: PhD students, PhD graduates, Postdoctoral fellows, Research grant holders, Medical residents 🔍 Research areas: dermatology; endocrinology; fertility/urology; pain medicine/orthopaedics/rheumatology; healthy aging/regenerative medicine 🌐 Nationality: any 🔹 Discover all the details and participate in the call by January 31, 2025: https://lnkd.in/dUrHXNwx #IBSAFoundation #scientificresearch #fellowships #supportscientist #research #ibsafoundationfellowships
-
Almost three years after the launch of the project 𝘚𝘢𝘪𝘭𝘪𝘯𝘨 𝘪𝘯𝘵𝘰 𝘵𝘩𝘦 𝘍𝘶𝘵𝘶𝘳𝘦.𝘛𝘰𝘨𝘦𝘵𝘩𝘦𝘳, the Class40 IBSA concludes its last race with a fantastic third place in the CIC Normandy Channel Race. The skippers ALBERTO BONA and Alberto Fabrizio Riva reached the podium after an exciting battle to the last breath, disputed in the English Channel with start and finish in Caen, France. An achievement that – crowning an unforgettable season – also celebrates the commitment and passion of the entire team. 🔹 Let’s retrace the highlights in our latest news: https://lnkd.in/dB_SsXMj #IBSA #CaringInnovation #SailingIntoTheFuture #Together IBSA Austria, IBSA France, IBSA Germany, IBSA Iberia, IBSA Italy, IBSA Nordic, IBSA Poland, IBSA Slovakia, IBSA Switzerland | SBO, IBSA UK, IBSA USA
Third place in the tenth Class40 IBSA race
ibsagroup.com
-
[Cultivate Knowledge, Cultivate Health 📚] When you happen to have to follow a therapy, do you always abide by the doctor's instructions? Did you know that this behavior has a specific term? It is called "therapeutic compliance" and is crucial to the success of any treatment. Indeed, accurately following prescriptions contributes to the effectiveness of treatment. Today we examine the topic in detail, together. 👇 #IBSA #CaringInnovation #CultivateKnowledgeCultivateHealth #TherapeuticCompliance
Therapeutic compliance: a central aspect for the success of therapies
IBSA Group auf LinkedIn
-
To create a drug, technological innovation and human input work in synergy. Artificial intelligence can be a valuable tool, but when it comes to crucial processes like weighing active ingredients, human experience makes the difference. We talked about this, and many other topics, with Simone Franchi, Health, Safety and Environment Specialist, and Mariano Canale, Production Operator. 🔹 And you? What do you think about artificial intelligence in the pharmaceutical industry? Share your opinion. #IBSA #CaringInnovation #WeAreIBSA #IBSAVoices
#IBSAVoices - Double Interview
-
The CIC Normandy Channel Race, the last regatta of the season for the Class40 IBSA, will start today at 1.02 pm CET. On board with our skipper ALBERTO BONA will be co-skipper Alberto Riva. Starting and arriving in Caen, France, 25 Class 40 boats will compete in this challenging regatta. 🔹 Follow the live tracker at: https://lnkd.in/dUHNZCR #IBSA #CaringInnovation #SailingIntoTheFuture #Together
Follow the race - CIC Normandy Channel Race
https://normandy-race.com/en/
-
Are digital interactive toys spying on young children? A study by the Universität Basel raises questions about the way many companies collect data, without making these procedures clear to parents. Some devices “silently” record every movement and choice a child makes, and then send the information to the company. 🔹 Find out more in the latest IBSA Foundation for scientific research blog article: https://lnkd.in/db9qpwxa #IBSA #CaringInnovation #ScienceBeyondFrontiers #IBSAFoundation #research #privacy #dataprotection
-
In recent years, the introduction of in silico medicine has introduced a significant transformation in the scientific research landscape. But what is it exactly? It’s an innovative approach that uses artificial intelligence to develop “digital twins” of patients, allowing treatments to be simulated and reducing the risks and times associated with clinical trials. Always in the forefront, IBSA is actively studying the potential of this technology, with four projects aimed at improving the safety and effectiveness of medicines. 🔹 Find out all the details in our latest news: https://lnkd.in/drNUYMMr #IBSA #CaringInnovation #pharmaceutical #healthtech
IBSA & in silico medicine
ibsagroup.com